Categories Earnings Calls, Health Care

Cigna Corp (CI) Q4 2020 Earnings Call

Cigna Corp  (NYSE: CI) Q4 2020 earnings call dated Feb. 04, 2021.

Corporate Participants:

Alexis Jones — Lead Principal, Investor Relations

David Cordani — President and Chief Executive Officer

Brian Evanko — Chief Financial Officer


Gary Taylor — JPMorgan Chase & Co — Analyst

Kevin Fischbeck — Bank of America — Analyst

Matt Borsch — BMO Capital Markets — Analyst

Ralph Giacobbe — Citigroup Global Markets, Inc. — Analyst

Robert Jones — Goldman Sachs — Analyst

George Hill — Deutsche Bank — Analyst

A.J. Rice — Credit Suisse — Analyst

David Windley — Jefferies LLC — Analyst

Justin Lake — Wolfe Research — Analyst

Steven Valiquette — Barclays — Analyst

Joshua Raskin — Nephron Research LLC — Analyst

Charles Rhyee — Cowen — Analyst

Lance Wilkes — Bernstein — Analyst

Scott Fidel — Stephens Inc. — Analyst

To read the full earnings call transcript, click here

Most Popular

Infographic: Highlights of DocuSign’s (DOCU) Q1 2024 results

DocuSign, Inc. (NASDAQ: DOCU), a leading provider of electronic signature solutions, Thursday reported first-quarter earnings. It also provided guidance for the second quarter and fiscal 2024. The company's top line

Macy’s (M): A few points to consider if you have an eye on this retailer

Shares of Macy’s, Inc. (NYSE: M) stayed in red on Thursday. The stock has dropped 22% year-to-date and 32% over the past 12 months. The retailer witnessed sales and profit

Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said its scientific co-founder Dr. Jonathan Kurtis received a new patent

Add Comment
Viewing Highlight